Saphetor Portal became VarSome Clinical!

Posted by Tomas Kucera on Feb 4, 2019 1:21:22 PM

The Saphetor Portal has been updated to version 7 as of February 2nd 2019 under the new name VarSome Clinical. There are many changes since version 6, and this release brings our clinical platform up to date with the features, databases and classification visible in the free VarSome.com. Our clinical platform has been on the market since 2015 and is already being used by dozens of institutional clients, such as diagnostic laboratories, hospitals, and universities from countries all over the world.

Dr. Erik Zmuda becomes a member of VarSome's Advisory Board

Posted by Tomas Kucera on Nov 26, 2018 11:04:29 AM

Banner - LI 1 - Nov

Lausanne, Switzerland - November 26, 2018 - Saphetor SA, a Swiss precision medicine company and a leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing, announced today that Dr. Erik Zmuda has become a member of its Advisory Board.

HPST to distribute VarSome Clinical in the Czech Republic

Posted by Tomas Kucera on Nov 20, 2018 11:37:31 AM

Lausanne, Switzerland - November 20, 2018 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a partnership with HPST, s.r.o., an authorized distributor of Agilent Technologies for the Czech Republic. Saphetor’s clinically-certified platform for fast and accurate variant discovery, annotation, and interpretation of NGS data for whole genomes, exomes, and gene panels extends HPST portfolio of tools and services for a wide range of its clients employing NGS technologies for clinical as well as for research purposes.

VarSome Search featured on GenomeWeb!

Posted by Tomas Kucera on Aug 9, 2018 11:21:00 PM

Saphetor’s performance at precision FDA contest

Posted by Tomas Kucera on Oct 15, 2017 8:11:00 PM

LAUSANNE, Switzerland – Saphetor S.A. is proud to report that its entry in the recent “Precision FDA” contest, organised by the Food and Drug Administration, met with resounding success.

Saphetor partners up with Supratech

Posted by Andreas Massouras on Aug 3, 2017 8:16:00 PM

LAUSANNE, Switzerland –Saphetor SA, the Swiss precision-medicine company dedicated to advancing personalized diagnostics, announced today that it will provide its proprietary platform for analyzing next-generation DNA sequencing data to Supratech Micropath (Ahmedabad, India), a reference and diagnostic lab with significant experience in clinical next-generation (NGS) DNA sequencing.